Trypanosomiasis: Clinical Trials

25 trials for Trypanosomiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 3 terminated, 2 recruiting. 25 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 14, Unknown 4, Terminated 3, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 28Completed 6, Terminated 1, Unknown 1

Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients
benznidazole 300 mg daily 8 weeks - Chronic Chagas Disease
Phase 3WithdrawnEvandro Chagas Institute of Clinical Research2025-01-302025-03-13
Stop Transmission of Gambiense Human African Trypanosomiasis
Acoziborole - Trypanosomiasis; African, Due to Trypanosoma Brucei Gambiense, Gambiense
Phase 3RecruitingInstitute of Tropical Medicine, Belgium25002024-03-152026-08-27
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases352022-07-092026-04-06
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases12082021-12-302025-03-20
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
Short regimen of benznidazole, Short treatment with benznidazole, Standard treatment with benznidazole - Chagas Disease
Phase 3RecruitingLaboratorio Elea Phoenix S.A.3002021-07-282023-11-30
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.
Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril - Chagas Cardiomyopathy
Phase 3UnknownUniversity of Sao Paulo General Hospital2002021-05-062024-04-04
Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases452019-09-292025-01-30
Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
Benznidazole - Chagas Disease
Phase 3Active not recruitingInsud Pharma1782019-09-192026-04-21
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Benznidazole, Placebo Oral Tablet - Chagas Disease
Phase 3CompletedTulane University School of Public Health and Tropical Medicine872019-06-012026-04-09
A Trial Testing Amiodarone in Chagas Cardiomiopathy
Amiodarone Hydrochloride, Placebo Oral Tablet - Chagas Cardiomyopathy
Phase 3UnknownFundación Cardioinfantil Instituto de Cardiología2002017-06-122017-06-21
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 3CompletedDrugs for Neglected Diseases1742016-11-102025-01-08
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases2082016-10-112025-09-17
A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi
Nifurtimox (Lampit, BAYA2502), Placebo - Chagas Disease
Phase 3CompletedBayer3302016-01-272024-08-19
CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Nifurtimox, Benznidazole, Placebo - Chagas Disease
Phase 2 / Phase 3UnknownUniversidad Autónoma de Bucaramanga5002015-08-012017-07-21
Physical Exercise Program in Chronic Chagas Heart Disease
Exercise, nutritional and pharmaceutical counceling, Nutritional and pharmaceutical counceling - Chagas Disease, Chagas Cardiomyopathy
Phase 3CompletedEvandro Chagas National Institute of Infectious Disease302015-03-012017-07-27
Cardiac Rehabilitation in Chagas Heart Failure
Exercise, nutritional and pharmaceutical counseling - Chagas Disease, Chagas Cardiomyopathy
Phase 2 / Phase 3CompletedEvandro Chagas National Institute of Infectious Disease122013-05-012015-08-05
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases3942012-10-012018-02-20
Selenium Treatment and Chagasic Cardiopathy (STCC)
Selenium, Placebo (for Selenium) - Chagas Disease
Phase 3UnknownOswaldo Cruz Foundation1302008-10-012015-11-10
Cell Therapy in Chagas Cardiomyopathy
Stem cell, Filgrastime (G-CSF), Standart therapy - Chagas Cardiomyopathy
Phase 3TerminatedMinistry of Health, Brazil1822006-01-012017-03-13
BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease
Benznidazole, Placebo - Chagas Disease, Trypanosomiasis
Phase 3CompletedPopulation Health Research Institute28542004-11-012020-03-03

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Chagas Disease (13)  ·  Trypanosomiasis, African (9)  ·  Chagas Cardiomyopathy (6)  ·  Infections (3)  ·  Heart Failure (2)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Dilated (1)  ·  Heart Diseases (1)  ·  Motor Activity (1)  ·  Neglected Diseases (1)

Broader conditions

Euglenozoa Infections (25)  ·  Parasitic Diseases (25)  ·  Protozoan Infections (25)  ·  Vector Borne Diseases (24)  ·  Infections (22)  ·  Cardiovascular Diseases (7)  ·  Heart Diseases (6)  ·  Cardiomyopathies (5)  ·  Chagas Disease (2)  ·  Behavior (1)  ·  Cardiomegaly (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)

Interventions

benzonidazole (7)  ·  Nifurtimox (5)  ·  Eflornithine (4)  ·  fexinidazole (3)  ·  Exercise (2)  ·  Amiodarone (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Bisoprolol (1)  ·  Control Groups (1)  ·  Enalapril (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Melarsoprol (1)  ·  SCYX 7158 (1)  ·  Selenium (1)  ·  Valsartan (1)

Sponsors

Drugs for Neglected Diseases (7)  ·  Epicentre (2)  ·  Evandro Chagas National Institute of Infectious Disease (2)  ·  Bayer (1)  ·  Evandro Chagas Institute of Clinical Research (1)  ·  Fundación Cardioinfantil Instituto de Cardiología (1)  ·  Fundación Cardiovascular de Colombia (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben (1)  ·  Insud Pharma (1)  ·  Laboratorio Elea Phoenix S.A. (1)  ·  Ministry of Health, Brazil (1)  ·  Oswaldo Cruz Foundation (1)  ·  Population Health Research Institute (1)  ·  Tulane University School of Public Health and Tropical Medicine (1)

Countries

Brazil (7)  ·  Democratic Republic of the Congo (7)  ·  Argentina (6)  ·  Colombia (6)  ·  Guinea (4)  ·  Bolivia (3)  ·  Uganda (3)  ·  Republic of the Congo (2)  ·  Central African Republic (1)  ·  El Salvador (1)  ·  Malawi (1)  ·  United States (1)

Top investigators

Gerardo Priotto, MD, MPH (2)  ·  Adellina R Riarte, MD (1)  ·  Andrea S Sousa, PhD (1)  ·  Carlos A Morillo, MD, FRCPC (1)  ·  Carlos Morillo, MD (1)  ·  Diego A Rodriguez, MD (1)  ·  Digas Ngolo Tete, MPH (1)  ·  Elena Nicco (1)  ·  Els Torreele, PhD (1)  ·  Enock Matovu, Prof (1)  ·  Fernanda Mendes, M.D. (1)  ·  Fernando Rosas, M.D. (1)  ·  Gerardo Priotto, MD MPH (1)

Results publications

PMID 8937280, PMID 9790423, PMID 11500748, PMID 16235350, PMID 16702588, PMID 19410718, PMID 19559476, PMID 19753491, PMID 20398860, PMID 21264349, PMID 22523306, PMID 24867876, PMID 25176015, PMID 25284194, PMID 2596992, PMID 26323937, PMID 27590681, PMID 29113731, PMID 29141857, PMID 29266804, PMID 30231899, PMID 30298996, PMID 31307503, PMID 32831069, PMID 33412557, PMID 34485877, PMID 36460027, PMID 36975790, PMID 37352322, PMID 3835868, PMID 38589582, PMID 40288399, PMID 40288400, PMID 41027700, PMID 41396086, PMID 6109902, PMID 7994859, PMID 8273735, PMID 8948328